Table 2.
Predictors of non-retention at 12 months in adult residents of SEARCH intervention communities who linked to HIV care after baseline CHC and before follow-up year 1 CHC (N =5683)
| Newly Linking to care (N = 1601) | Previously in Care (N = 4082) | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Predictor | Hazard Ratio | 95% CI | Adj Hazard Ratio | 95% CI | Hazard Ratio | 95% CI | Adj Hazard Ratio | 95% CI |
| Region | ||||||||
| Kenya | ref | ref | ref | ref | ||||
| Uganda-East | 1.90 | 0.82–4.43 | 2.52 | 1.04–6.12 | 0.64 | 0.15–2.79 | 0.53 | 0.12–2.32 |
| Uganda-West | 0.95 | 0.36–2.51 | 0.88 | 0.32–2.42 | 0.28 | 0.13–0.60 | 0.25 | 0.12–0.52 |
| Sex | ||||||||
| Male | ref | ref | ref | ref | ||||
| Female | 1.08 | 0.80–1.47 | 0.76 | 0.54–1.06 | 1.01 | 0.71–1.43 | 0.84 | 0.59–1.21 |
| Age | ||||||||
| 15–24 | 3.94 | 2.72–5.70 | 3.78 | 2.48–5.76 | 2.48 | 1.57–3.90 | 2.70 | 1.70–4.29 |
| 25–29 | 2.39 | 1.61–3.55 | 2.51 | 1.67–3.77 | 1.48 | 0.95–2.32 | 1.59 | 1.01–2.51 |
| >= 30 | ref | ref | ref | ref | ||||
| Education | ||||||||
| No School | 0.53 | 0.30–0.94 | 0.78 | 0.44 – 1.40 | 0.83 | 0.43–1.60 | ||
| Primary | ref | ref | ref | |||||
| Any secondary or further | 0.78 | 0.50–1.23 | 0.76 | 0.48 – 1.21 | 0.88 | 0.48–1.61 | ||
| Occupation | ||||||||
| Formal | ref | ref | ref | |||||
| Informal – high risk | 1.71 | 0.37–7.86 | 1.37 | 0.28 – 6.73 | 1.01 | 0.29–3.49 | ||
| Informal – low risk | 2.16 | 0.67–7.01 | 1.79 | 0.51 – 6.28 | 1.10 | 0.44–2.80 | ||
| No job | 4.61 | 1.30–16.4 | 2.79 | 0.72 – 10.7 | 2.41 | 0.83–6.94 | ||
| Other | 2.32 | 0.59–9.2 | 1.79 | 0.42 – 7.58 | 0.68 | 0.18–2.59 | ||
| Access to a mobile phone | ||||||||
| Yes | ref | ref | ref | |||||
| No | 1.27 | 0.92–1.76 | 1.94 | 1.35–2.77 | 1.94 | 1.36 – 2.77 | ||
| Mobility | ||||||||
| Stable resident | ref | ref | ||||||
| Not stable resident | 1.77 | 0.87–3.60 | 0.82 | 0.20–3.39 | ||||
| Pre-ART CD4 | ||||||||
| Below country treatment guidelines | ref | ref | ref | ref | ||||
| Above country treatment guidelines | 0.68 | 0.50–0.93 | 0.62 | 0.45–0.84 | 0.75 | 0.40–1.38 | 0.63 | 0.34–1.17 |
| Site of testing | ||||||||
| CHC | ref | ref | ||||||
| HBT | 0.93 | 0.61–1.40 | 0.90 | 0.56–1.42 | ||||
| Time to link | ||||||||
| <= 30 days | ref | ref | ||||||
| > 30 days | 1.52 | 1.11–2.10 | 1.41 | 1.03–1.95 | ||||
Abbreviations: CI = Confidence Interval; CHC = Community Health Campaign; HBT = Home-based Testing
Country guidelines for treatment were to initiate ART at CD4 < 350 cells/ml until December 2013 in Uganda and until June 2014 in Kenya, after which country treatment guidelines were changed to reflect the 2013 WHO guidelines of ART initiation at CD4 < 500 cells/ml